Use and method of bispecific antibody-drug conjugates for treating tumor diseases

TW202635351APending Publication Date: 2026-09-01SICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114140464
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-10-10
Filing Date
2025-10-20
Publication Date
2026-09-01

Smart Images

  • Figure TWG2TA001074416_001
    Figure TWG2TA001074416_001
  • Figure TWG2TA001074416_002
    Figure TWG2TA001074416_002
  • Figure TWG2TA001074416_003
    Figure TWG2TA001074416_003
Patent Text Reader

Abstract

The present application relates to the use of antibody-drug conjugates in treating diseases associated with abnormal cell activity in subjects, such as tumor diseases, wherein the relevant genes of the subjects suffering from the tumor diseases are mutant or wild-type, and they have undergone or have not undergone first-line or second-line treatment.
Need to check novelty before this filing date? Find Prior Art